CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma

Salman J Khan; Muhamad Alhaj Moustafa

doi:10.21037/cco-23-95

CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma

Chin Clin Oncol. 2024 Apr;13(2):31. doi: 10.21037/cco-23-95. Epub 2024 Apr 18.

Authors

Salman J Khan¹, Muhamad Alhaj Moustafa²

Affiliations

¹ Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA; Public Health, University of Massachusetts, Amherst, MA, USA.
² Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL, USA.

PMID: 38644547
DOI: 10.21037/cco-23-95

No abstract available

Keywords: CD19-directed chimeric antigen receptor-T cell therapy (CD19-directed CAR-T cell therapy); Diffuse large B cell lymphoma (DLBCL); extra-diffuse large B cell lymphoma (extra-nodal DLBCL).

Publication types

Editorial

MeSH terms

Humans
Immunotherapy, Adoptive* / methods
Lymphoma, Large B-Cell, Diffuse* / therapy